EUVIMEDEUVIMED entdecken
Crossref

A Review of Recent HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitor Research Activity

Jeffrey Corbett

Current Medicinal Chemistry -Anti-Infective Agents · 2002

DOI: 10.2174/1568012023354938 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Current Medicinal Chemistry -Anti-Infective Agents, 2002. Verfasst von Jeffrey Corbett. Die Arbeit wurde bisher 15-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This non-nucleoside reverse transcriptase inhibitor review covers the patent and published literature from January, 1998-August, 2001. Major advances have been made in the past decade in discovering non-nucleoside reverse transcriptase inhibitors that are effective in inhibiting replication of wild-type virus. Attention is now focused upon the discovery of agents that are effective in inhibiting replication of virus with singly and doubly mutated HIV-1 reverse transcriptase. Notable advances in the discovery of such broad spectrum therapeutics are SG-153 and the quinazolines DPC961 and DPC083. Attempts at discovering other broad spectrum anti-viral agents are presented herein. Keywords: Hiv-1 non-nucleoside reverse transcriptase inhibitor, nnrti, stavudine

Zitieren

APA

Corbett, J. (2002). A Review of Recent HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitor Research Activity. Current Medicinal Chemistry -Anti-Infective Agents. https://doi.org/10.2174/1568012023354938

Vancouver

Corbett J. A Review of Recent HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitor Research Activity. Current Medicinal Chemistry -Anti-Infective Agents. 2002. doi:10.2174/1568012023354938

BibTeX
@article{Corbett2002,
  author = {Corbett, Jeffrey},
  title = {A Review of Recent HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitor Research Activity},
  journal = {Current Medicinal Chemistry -Anti-Infective Agents},
  year = {2002},
  doi = {10.2174/1568012023354938}
}
Kostenlos starten →